More Articles

Challenges facing the US biosimilars market Reports | Posted 19/07/2019

At the 17th Biosimilar Medicines Conference in The Netherlands, Dr Gillian Woolett of US healthcare consultancy Avalere Health discussed challenges facing the biosimilars market in the US and upcom...

FDA approves bevacizumab biosimilar Zirabev Biosimilars/News | Posted 19/07/2019

US-based pharma giant Pfizer announced on 28 June 2019 that it had received approval from the US Food and Drug Administration (FDA) for its bevacizumab biosimilar Zirabev (PF-06439535).

Real-world data confirms safety of infliximab biosimilar CT-P13 Biosimilars/Research | Posted 19/07/2019

Positive real-world data has been presented for Celltrion’s infliximab biosimilar CT P13 at the European Congress of Rheumatology 2019 (EULAR 2019).

Asian specialists recommendations for off-patent biologicals in IBD Biosimilars/Research | Posted 19/07/2019

Gastroenterologists from across Asia have published a list of recommendations for the use of biologicals and off-patent biologicals in inflammatory bowel disease (IBD) in Asia [1].

Positive phase III results for trastuzumab follow-on biological Zedora Biosimilars/Research | Posted 19/07/2019

Results of a post-marketing study of Biocon and Mylan’s trastuzumab biosimilar Zedora (MYL-1401O) compared to Herceptin (trastuzumab) has shown equivalent safety data to the originator biological i...

STADA and Xbrane strengthen biosimilars collaboration Pharma News | Posted 19/07/2019

German generics giant Stada Arzneimittel (Stada) and Swedish biotech company Xbrane Bioscience (Xbrane) announced on 31 May 2019 that they have expanded their strategic biosimilar development partn...

Gilead’s Truvada will face generics competition in 2020 Generics/General | Posted 19/07/2019

Gilead Sciences’ HIV blockbuster Truvada will face generics competition in the US in 2020, a year earlier than expected.

EMA approves two generics for fungal infections Generics/News | Posted 19/07/2019

On 29 May 2019, the European Medicine Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorization for two n...